Spyre Therapeutics, Inc. · NASDAQ:SYRE

Burrows Scott L sold 12,500 Spyre Therapeutics, Inc. shares (Form 4)

Traded May 1, 2026 · Filed May 1, 2026

On May 1, 2026, Burrows Scott L (Chief Financial Officer) sold 12,500 Spyre Therapeutics, Inc. shares at US$71.37 for US$892K under a trading plan, leaving 97,994 shares. Filed May 1, 2026 (Form 4).

Sold
12,500 shares
Price
US$71.37
Value
US$892K
Holding after
97,994 shares
Trading plan
Yes (Made under a plan set in advance)
Role
Chief Financial Officer

The filing in full

DateSecurityTransactionSharesPriceHolding afterOwnership
May 1, 2026Common StockOption exercise12,500US$14.50110,494Direct
May 1, 2026Common StockSale12,500US$71.3797,994Direct

Source

View original at SEC

Related